Corcept Therapeutics
CORT
#2078
Rank
HK$70.62 B
Marketcap
HK$670.29
Share price
1.71%
Change (1 day)
44.97%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : HK$49.49 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is HK$49.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$53.84 M4466%
2023-12-31HK$1.17 M-86.79%
2022-12-31HK$8.93 M117.74%
2021-12-31HK$4.1 M-79.26%
2020-12-31HK$19.77 M-26.63%
2019-12-31HK$26.95 M
2018-12-31N/A
2016-12-31HK$0.11 B-1.96%
2015-12-31HK$0.11 B58.68%
2014-12-31HK$73.09 M64.14%
2013-12-31HK$44.53 M116.81%
2012-12-31HK$20.54 M
2010-12-31N/A-100%
2009-12-31HK$0.04 M-62.37%
2008-12-31HK$0.12 M-45.32%
2007-12-31HK$0.22 M-30.78%
2006-12-31HK$0.32 M-21.98%
2005-12-31HK$0.41 M
2003-12-31HK$4.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$356.49 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.33 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.27 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$330.89 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$473.67 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$322.08 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$2.38 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.93 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.70 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA